Research in CML is ongoing, focusing on improving existing treatments and finding new therapeutic targets. Studies are exploring the potential of combination therapies, the role of immunotherapy, and the development of next-generation TKIs. Additionally, efforts are being made to understand the mechanisms of resistance to current treatments.
